Igor Dzhura works with ReproSource, Inc

Igor Dzhura is a Malden, MA based professional experienced in supporting research different fields – microbiology, biochemistry, cancer research, ion channels regulation and drug discovery. He is a diligent person with excellent troubleshooting, problem solving, interpersonal, and organizational skills. He holds good supervisory, teaching, & lab manager experience, and has successfully managed external collaborations & CRO’s. He holds a Master of Science (major in Biophysics) from National Kiev University, and graduated in the year 1998. Prior to this, he completed his bachelor degree (major in biology/chemistry) in 1995 from the same university.

Currently, Igor Dzhura works with ReproSource, Inc. in the Department of Immunology. Serving the position of Scientist/Medical Technologist, he is responsible for developing & validating new assays for flow cytomerty, management assay NKA, IMX, FOXP3, T-RIP, and working under CLIA, CAP. 

Prior to this, he worked with Novartis Institute for BioMedical Research as a Scientist II. He worked for this institute for four years, and fulfilled an array of responsibilities. These included designing, implementing, & validating new & existing ion channels and GPCR/M1 based functional assays for target engagement, profiling and HTS, cardiac safety profiling, managing external collaboration and CROs, and developing & validating new assays for drug recovery (for which he received 2 awards). Apart from that, Igor also identified cutting-edge techniques for ion channels and GPCR electrophysiological assays and Lead drug discovery and validated targets/mechanism of action for a variety of natural products/drugs for a multiple projects (oncology, malaria, diabetes, muscle disorder).

In addition, Igor Dzhura‘s professional experience also includes Instructor/Lab Manager at Boston University (in 2010), Senior Research Associate at SUNY Department of Medicine & Joslin Diabetes Center (from 2008 to 2010), and Research Associate at Vanderbilt University Medical Center (from 2000 to 2008) & Bogomoletz Institute of Physiology (from 1998 to 2000).